eFFECTOR Therapeutics, Inc. (EFTR)
OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
At close: Jul 20, 2026
eFFECTOR Therapeutics Market Cap
eFFECTOR Therapeutics has a market cap or net worth of $2.35 thousand as of July 21, 2026. Its market cap has increased by 149.95% in one year.
Market Cap
2.35K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since March 1, 2021, eFFECTOR Therapeutics's market cap has decreased from 218.96M to 2.35K, a decrease of -100.00%. That is a compound annual growth rate of -88.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 2.35K | 149.95% |
| Dec 31, 2025 | 941.00 | - |
| Dec 31, 2024 | 941.00 | -100.00% |
| Dec 29, 2023 | 30.20M | 68.61% |
| Dec 30, 2022 | 17.91M | -94.64% |
| Dec 31, 2021 | 334.28M | 52.66% |
| Mar 1, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Baseline Productions | 4.11K |
| EV Biologics | 4.09K |
| Xeno Transplants | 4.04K |
| Synovics Pharmaceuticals | 3.65K |
| Rebus Holdings | 3.21K |
| Hemagen Diagnostics | 3.10K |
| Anthera Pharmaceuticals | 2.62K |
| Aditxt | 2.42K |